Primary Sclerosing Cholangitis Market is Anticipated to Witness...

Ajout d’un nouvel article Health

2024-02-19 07:03:22 -

Primary Sclerosing Cholangitis Market is Anticipated to Witness Moderate Growth Owing to Increasing Research Funding and Innovation in Drugs

The primary sclerosing cholangitis market comprises drugs and treatments to manage the symptoms of primary sclerosing cholangitis, a rare disorder that causes inflammation and scarring in the bile ducts of the liver. Primary sclerosing cholangitis (PSC) is a rare long-term disease that causes narrowing and scarring of the bile ducts inside and outside the liver. Patients with PSC experience...

0 Commentaires 0 Parts 987 Vue 0 Aperçu